Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Capital Employed (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Capital Employed for 14 consecutive years, with 0.06% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 6.0% to 0.06% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.06%, a 6.0% increase, with the full-year FY2025 number at 0.05%, down 3.0% from a year prior.
  • Return on Capital Employed was 0.06% for Q4 2025 at Aytu Biopharma, down from 0.06% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q1 2024 to a low of 1.24% in Q2 2022.
  • A 5-year average of 0.39% and a median of 0.18% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: tumbled -78bps in 2022, then skyrocketed 100bps in 2023.
  • Aytu Biopharma's Return on Capital Employed stood at 0.55% in 2021, then crashed by -85bps to 1.01% in 2022, then soared by 91bps to 0.09% in 2023, then tumbled by -37bps to 0.12% in 2024, then soared by 48bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Return on Capital Employed are 0.06% (Q4 2025), 0.06% (Q3 2025), and 0.05% (Q2 2025).